KMI
59
2
BWA
45
-4
WMB
60
4
GOOGL
56
2
FMC
40
4
ED
53
4
OMC
64
-2
XRAY
31
-3
DTE
63
7
EMC
53
-3
IBM
81
3
COST
56
3
STT
51
-5
PDCO
54
-4
HBI
62
4
CA
36
-4
CHD
54
6
GOOG
67
2
NWSA
47
-2
AMG
41
-3
KMI
59
2
BWA
45
-4
WMB
60
4
GOOGL
56
2
FMC
40
4
ED
53
4
OMC
64
-2
XRAY
31
-3
DTE
63
7
EMC
53
-3
IBM
81
3
COST
56
3
STT
51
-5
PDCO
54
-4
HBI
62
4
CA
36
-4
CHD
54
6
GOOG
67
2
NWSA
47
-2
AMG
41
-3
Financhill
Back

Western Asset High Yield Defined Opps. Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
49

HYI
Western Asset High Yield Defined Opps.

Last Price:
12.39
Seasonality Move:
-2.22%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
49
Western Asset High Yield Defined Opps. (HYI) is a Sell

Is Western Asset High Yield Defined Opps. a Buy, Sell or Hold?

  • The current Western Asset High Yield Defined Opps. [HYI] share price is $12.36. The Score for HYI is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • HYI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

HYI Stock Price Chart

What is Western Asset High Yield Defined Opps.'s stock price today?

  • The Western Asset High Yield Defined Opps. share price today is $12.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HYI is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

HYI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 71.43 Buy
Chaikin Money Flow: -15912 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.03 - 12.23) Buy
Bollinger Bands (100): (11.52 - 12.02) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

HYI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.23 Buy
20-day SMA: 12.12 Buy
50-day SMA: 11.97 Buy
200-day SMA: 11.86 Buy
8-day EMA: 12.25 Buy
20-day EMA: 12.15 Buy
50-day EMA: 12 Buy
200-day EMA: 11.84 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Western Asset High Yield Defined Opps. Earnings Growth & HYI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Western Asset High Yield Defined Opps. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):